Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cross-over Trial of Medical Treatment for GERD in Preterm Infants
NCT00131248Phase 3Completed
- Sponsor
- UTHealth Houston
- Start
- Apr 2004
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of metoclopramide and ranitidine in gastroesophageal reflux disease (GERD) (2 arms), sponsored by UTHealth Houston. Primary endpoint: Bradycardia Episodes/Day at 7 days. Started Apr 2004; status: completed.
02
Drugs
metoclopramideranitidine
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00131248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00131248.